Home > National Drug Code (NDC) > ATRIPLEX WRIGHTII POLLEN

ATRIPLEX WRIGHTII POLLEN - 0268-1481-50 - (Saltbush Annual Atriplex)

Alphabetical Index


Drug Information of ATRIPLEX WRIGHTII POLLEN

Product NDC: 0268-1481
Proprietary Name: ATRIPLEX WRIGHTII POLLEN
Non Proprietary Name: Saltbush Annual Atriplex
Active Ingredient(s): .025    g/mL & nbsp;   Saltbush Annual Atriplex
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of ATRIPLEX WRIGHTII POLLEN

Product NDC: 0268-1481
Labeler Name: ALK-Abello, Inc.
Product Type: NON-STANDARDIZED ALLERGENIC
FDA Application Number: BLA103753
Marketing Category: BLA
Start Marketing Date: 19650101

Package Information of ATRIPLEX WRIGHTII POLLEN

Package NDC: 0268-1481-50
Package Description: 50 mL in 1 VIAL, MULTI-DOSE (0268-1481-50)

NDC Information of ATRIPLEX WRIGHTII POLLEN

NDC Code 0268-1481-50
Proprietary Name ATRIPLEX WRIGHTII POLLEN
Package Description 50 mL in 1 VIAL, MULTI-DOSE (0268-1481-50)
Product NDC 0268-1481
Product Type Name NON-STANDARDIZED ALLERGENIC
Non Proprietary Name Saltbush Annual Atriplex
Dosage Form Name INJECTION, SOLUTION
Route Name SUBCUTANEOUS
Start Marketing Date 19650101
Marketing Category Name BLA
Labeler Name ALK-Abello, Inc.
Substance Name ATRIPLEX WRIGHTII POLLEN
Strength Number .025
Strength Unit g/mL
Pharmaceutical Classes Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of ATRIPLEX WRIGHTII POLLEN


General Information